MyAverix Finance
SHE · Healthcare
Enwei Pharmaceutical Co. Ltd. A (301331)
Drug Manufacturers - Specialty & Generic
Enwei Pharmaceutical Co. Ltd. A (301331) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $2.68B, P/E ratio is 50.15, net margin is 5.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301331
Enwei Pharmaceutical Co. Ltd. A (301331) — FAQ
What is Enwei Pharmaceutical Co. Ltd. A's market cap?
Enwei Pharmaceutical Co. Ltd. A (301331) has a reported market cap of $2.68B (data as of 2026-03-29).
What is 301331's P/E ratio?
The price-to-earnings (P/E) ratio for Enwei Pharmaceutical Co. Ltd. A (301331) is 50.15 (data as of 2026-03-29).
Does Enwei Pharmaceutical Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Enwei Pharmaceutical Co. Ltd. A (301331). Check the MyAverix Finance app for the latest dividend data.
What sector is Enwei Pharmaceutical Co. Ltd. A in?
Enwei Pharmaceutical Co. Ltd. A (301331) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301331 listed on?
301331 is listed on SHE.
What is Enwei Pharmaceutical Co. Ltd. A's net margin?
Enwei Pharmaceutical Co. Ltd. A (301331) reports a net margin of 5.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.